Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats.
Ammonia toxicity
Apoptosis
Episodic hepatic encephalopathy
Neurodegeneration
Neurological complications
Proteomics
Journal
JHEP reports : innovation in hepatology
ISSN: 2589-5559
Titre abrégé: JHEP Rep
Pays: Netherlands
ID NLM: 101761237
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
05
03
2023
revised:
25
07
2023
accepted:
31
08
2023
medline:
9
11
2023
pubmed:
9
11
2023
entrez:
9
11
2023
Statut:
epublish
Résumé
Hepatic encephalopathy (HE) is defined as a reversible syndrome and therefore should resolve following liver transplantation (LT). However, neurological complications have been reported in up to 47% of LT recipients, which have been documented to be associated with a history of overt HE pre-LT. We hypothesise that multiple episodes of HE lead to permanent cell injury and exacerbate neurological dysfunction. Our goal was to evaluate the impact of cumulative HE episodes on neurological status and brain integrity in rats with chronic liver disease. Episodes of overt HE (loss of righting reflex) were induced following injection of ammonium acetate in bile duct ligation (BDL) rats (BDL-Ammonia) every 4 days starting at week 3 post-BDL. Neurobehaviour was evaluated after the last episode. Upon sacrifice, plasma ammonia, systemic oxidative stress, and inflammation markers were assessed. Neuronal markers including neuron-specific nuclear antigen and SMI311 (anti-neurofilament marker) and apoptotic markers (cleaved caspase-3, Bax, and Bcl2) were measured. Total antioxidant capacity, oxidative stress marker (4-hydroxynonenal), and proinflammatory cytokines (tumour necrosis factor-alpha and interleukin-1β) were measured in brain (hippocampus, frontal cortex, and cerebellum). Proteomic analysis was conducted in the hippocampus. In hippocampus of BDL-Ammonia rats, cleaved caspase-3 and Bax/Bcl2 ratio were significantly increased, whereas NeuN and SMI311 were significantly decreased compared with BDL-Vehicle rats. Higher levels of oxidative stress-induced post-translational modified proteins were found in hippocampus of BDL-Ammonia group which were associated with a lower total antioxidant capacity. Ammonia-induced episodes of overt HE caused neuronal cell injury/death in BDL rats. These results suggest that multiple bouts of HE can be detrimental on the integrity of the brain, translating to irreversibility and hence neurological complications post-LT. Hepatic encephalopathy (HE) is defined as a reversible neuropsychiatric syndrome resolving following liver transplantation (LT); however, ∼47% of patients demonstrate neurological impairments after LT, which are associated with a previous history of overt HE pre-LT. Our study indicates that multiple episodes of overt HE can cause permanent neuronal damage which may lead to neurological complications after LT. Nevertheless, preventing the occurrence of overt HE episodes is critical for reducing the risk of irreversible neuronal injury in patients with cirrhosis.
Sections du résumé
Background & Aims
UNASSIGNED
Hepatic encephalopathy (HE) is defined as a reversible syndrome and therefore should resolve following liver transplantation (LT). However, neurological complications have been reported in up to 47% of LT recipients, which have been documented to be associated with a history of overt HE pre-LT. We hypothesise that multiple episodes of HE lead to permanent cell injury and exacerbate neurological dysfunction. Our goal was to evaluate the impact of cumulative HE episodes on neurological status and brain integrity in rats with chronic liver disease.
Methods
UNASSIGNED
Episodes of overt HE (loss of righting reflex) were induced following injection of ammonium acetate in bile duct ligation (BDL) rats (BDL-Ammonia) every 4 days starting at week 3 post-BDL. Neurobehaviour was evaluated after the last episode. Upon sacrifice, plasma ammonia, systemic oxidative stress, and inflammation markers were assessed. Neuronal markers including neuron-specific nuclear antigen and SMI311 (anti-neurofilament marker) and apoptotic markers (cleaved caspase-3, Bax, and Bcl2) were measured. Total antioxidant capacity, oxidative stress marker (4-hydroxynonenal), and proinflammatory cytokines (tumour necrosis factor-alpha and interleukin-1β) were measured in brain (hippocampus, frontal cortex, and cerebellum). Proteomic analysis was conducted in the hippocampus.
Results
UNASSIGNED
In hippocampus of BDL-Ammonia rats, cleaved caspase-3 and Bax/Bcl2 ratio were significantly increased, whereas NeuN and SMI311 were significantly decreased compared with BDL-Vehicle rats. Higher levels of oxidative stress-induced post-translational modified proteins were found in hippocampus of BDL-Ammonia group which were associated with a lower total antioxidant capacity.
Conclusions
UNASSIGNED
Ammonia-induced episodes of overt HE caused neuronal cell injury/death in BDL rats. These results suggest that multiple bouts of HE can be detrimental on the integrity of the brain, translating to irreversibility and hence neurological complications post-LT.
Impact and implications
UNASSIGNED
Hepatic encephalopathy (HE) is defined as a reversible neuropsychiatric syndrome resolving following liver transplantation (LT); however, ∼47% of patients demonstrate neurological impairments after LT, which are associated with a previous history of overt HE pre-LT. Our study indicates that multiple episodes of overt HE can cause permanent neuronal damage which may lead to neurological complications after LT. Nevertheless, preventing the occurrence of overt HE episodes is critical for reducing the risk of irreversible neuronal injury in patients with cirrhosis.
Identifiants
pubmed: 37942225
doi: 10.1016/j.jhepr.2023.100904
pii: S2589-5559(23)00235-5
pmc: PMC10628859
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100904Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest that pertain to this issue. Please refer to the accompanying ICMJE disclosure forms for further details.
Références
Neuroscience. 2007 Mar 16;145(2):495-504
pubmed: 17257765
J Clin Transl Hepatol. 2019 Dec 28;7(4):352-361
pubmed: 31915605
Metab Brain Dis. 2010 Mar;25(1):17-21
pubmed: 20217200
Sci Rep. 2017 Jul 27;7(1):6683
pubmed: 28751644
Liver Int. 2021 May;41(5):1020-1032
pubmed: 33548108
Hepatology. 2007 Mar;45(3):549-59
pubmed: 17326150
JHEP Rep. 2022 May 23;4(8):100510
pubmed: 35845295
J Cereb Blood Flow Metab. 2017 Mar;37(3):927-937
pubmed: 27154504
Metab Brain Dis. 2001 Jun;16(1-2):3-11
pubmed: 11726086
Am J Physiol Gastrointest Liver Physiol. 2016 Feb 1;310(3):G163-70
pubmed: 26635319
Neuroscience. 2005;133(2):471-84
pubmed: 15878804
Liver Transpl. 2019 Mar;25(3):469-487
pubmed: 30697911
Am J Gastroenterol. 2014 Nov;109(11):1757-63
pubmed: 25178701
Sci Rep. 2018 Feb 14;8(1):3004
pubmed: 29445232
Brain Circ. 2017 Apr-Jun;3(2):87-108
pubmed: 30276309
Hepatology. 2006 Jun;43(6):1257-66
pubmed: 16729306
Aliment Pharmacol Ther. 2011 Apr;33(7):739-47
pubmed: 21306407
J Neurosci Res. 2021 Sep;99(9):2287-2304
pubmed: 34061383
Gastroenterology. 2009 Sep;137(3):885-91, 891.e1
pubmed: 19501587
Hepatol Commun. 2019 Sep 06;3(11):1510-1519
pubmed: 31701074
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S7-S20
pubmed: 26041962
Int J Biochem Cell Biol. 2012 Sep;44(9):1385-9
pubmed: 22634605
Neurochem Res. 2021 Oct;46(10):2612-2625
pubmed: 34129161
Gastroenterology. 2010 Jun;138(7):2332-40
pubmed: 20178797
Ann Med. 2005;37(8):603-12
pubmed: 16338762
Front Neurol Neurosci. 2014;34:95-108
pubmed: 24777134
J Cereb Blood Flow Metab. 2014 Dec;34(12):1877-86
pubmed: 25227607
J Alzheimers Dis. 2007 Jun;11(3):385-97
pubmed: 17851188
Radiology. 2013 Jan;266(1):261-70
pubmed: 23047839
Dig Dis Sci. 2019 Jun;64(6):1448-1457
pubmed: 30863953
DNA Cell Biol. 2001 Nov;20(11):683-95
pubmed: 11788046
Front Behav Neurosci. 2021 Jun 11;15:680042
pubmed: 34177480
Hepatology. 2011 Jun;53(6):1995-2002
pubmed: 21384402
Liver Transpl. 2011 Jan;17(1):38-46
pubmed: 21254343
Mol Med Rep. 2016 Mar;13(3):2247-52
pubmed: 26796245
Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):142-7
pubmed: 23142228
Hepatology. 2010 Jul;52(1):256-65
pubmed: 20583283
Glia. 2005 Jun;50(4):427-434
pubmed: 15846805
Liver Int. 2021 Jul;41(7):1474-1488
pubmed: 33900013
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S69-74
pubmed: 26041961
N Engl J Med. 2010 Mar 25;362(12):1071-81
pubmed: 20335583
Psychiatr Danub. 2012 Jun;24(2):152-8
pubmed: 22706413
Br J Pharmacol. 2008 Jan;153(1):6-20
pubmed: 17643134
Free Radic Biol Med. 2022 Jan;178:295-307
pubmed: 34890769
Annu Rev Psychol. 2010;61:49-79, C1-4
pubmed: 19575620
Nat Rev Neurol. 2019 Oct;15(10):565-581
pubmed: 31501588
J Neurochem. 2009 Oct;111(2):460-72
pubmed: 19686238
Free Radic Biol Med. 2012 Apr 1;52(7):1228-35
pubmed: 22300646
J Physiol. 2016 Dec 15;594(24):7341-7360
pubmed: 27558544
Metab Brain Dis. 2017 Apr;32(2):529-538
pubmed: 28012068
J Hepatol. 2019 Sep;71(3):505-515
pubmed: 31173812
J Clin Exp Hepatol. 2018 Sep;8(3):294-300
pubmed: 30302047
Metab Brain Dis. 2009 Mar;24(1):95-102
pubmed: 19104924
Front Synaptic Neurosci. 2018 Nov 27;10:45
pubmed: 30542276
Liver Transpl. 2009 Feb;15(2):184-92
pubmed: 19177446
Metab Brain Dis. 2017 Apr;32(2):513-518
pubmed: 27981407
Oxid Med Cell Longev. 2014;2014:360438
pubmed: 24999379
Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19;369(1654):20140046
pubmed: 25225104
J Hepatol. 2020 Dec;73(6):1526-1547
pubmed: 33097308
Cell Tissue Res. 2009 Feb;335(2):301-16
pubmed: 18989702